Altos Labs utilizes cellular rejuvenation programming to restore cellular health and resilience, targeting the underlying mechanisms of disease and injury. By enhancing the ability of cells to resist stressors, the company aims to improve overall health and mitigate age-related disabilities.
Funding
$5M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Age-related diseases and injuries stem from cellular decline, where cells lose their ability to resist stressors and maintain optimal function. This deterioration leads to a cascade of health issues and disabilities as individuals age.
Solution
Altos Labs is developing cellular rejuvenation programming techniques aimed at restoring cellular health and resilience. By reprogramming cells, Altos Labs seeks to enhance their ability to withstand stressors, thereby reversing or mitigating the effects of disease, injury, and age-related disabilities. The company focuses on translating early scientific findings into practical applications that can improve overall health and extend healthy lifespan. This approach targets the underlying mechanisms of aging and disease, offering a potential pathway to prevent or treat a wide range of conditions.
Target Audience
Altos Labs' work targets individuals at risk of or affected by age-related diseases, injuries, and disabilities, as well as healthcare providers and researchers seeking innovative therapeutic approaches.
Features
- Cellular reprogramming methodologies to restore cell vitality
- Research into the deep biology of cell rejuvenation
- Focus on enhancing cellular resistance to stressors
- Development of therapies targeting age-related diseases and injuries